Assessment of Biogazelle’s Workflow in Small RNA sequencing of RNA Isolated from Body Fluids

Biogazelle’s workflow, starting from total RNA extracted from 200 µl of body fluid, is optimized to tackle the particular challenges associated with analysis of degraded RNA samples. It enables researchers to start applying the power of next generation sequencing technology to miRNA expression studies on RNA isolated from various body fluids. This application note assess’ the performance of Biogazelle’s workflow by performing small RNA sequencing on RNA extracted from a plasma sample, 2 cerebrospinal fluid samples and 8 serum samples, taken from healthy individuals and patients diagnosed with colorectal cancer (CRC).